WPD Pharmaceuticals Provides Update on WPD101, a Drug Candidate Targeting GBM Tumors
VANCOUVER, British Columbia, July 28, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (“WPD” or the “Company”) (CSE: WBIO) (FSE: 8SV1), […]
Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN
CAMBRIDGE, Mass., July 28, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced that its novel drug candidate, […]
Corning Reports Second-Quarter 2020 Results
CORNING, NY, July 28, 2020 (GLOBE NEWSWIRE) — Corning Incorporated (NYSE: GLW) today announced results for the second quarter ended […]
Sol-Gel Technologies Partnered Generic Product Expected to Launch in the Second Quarter of 2021
NESS ZIONA, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on […]
Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra®
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
Cowen Announces Record Financial Results for Second Quarter 2020
Reports Record 2Q20 US GAAP Net Income of $112.1 million or $3.83 per shareRecord Economic Operating Income of $166.9 million, […]
Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020
CRANBURY, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a […]
XP Inc. to Announce Second Quarter 2020 Results and Host Webcast After Market Close on Tuesday, August 11, 2020
SÃO PAULO, Brazil, July 28, 2020 (GLOBE NEWSWIRE) — XP Inc. (Nasdaq: XP), a leading, technology-driven financial services platform and […]
Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
AUSTIN, Texas, July 28, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced the successful completion of […]
AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic Agent
Next-generation PET tracer detects pathological alpha-synuclein with improved signal-to-noise ratioOral presentation at AAIC further demonstrates the strength of AC Immune’s […]
